Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo- controlled extension study (vol 11, pg 425, 2023)

被引:0
|
作者
Menzies-Gow, A.
Wechsler, M. E.
Brightling, C. E.
机构
来源
LANCET RESPIRATORY MEDICINE | 2023年 / 11卷 / 03期
关键词
D O I
10.1016/S2213-2600(23)00048-6
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:E25 / E25
页数:1
相关论文
共 50 条
  • [41] Long-term Efficacy and Safety of Adjunctive Cenobamate in Patients With Uncontrolled Focal Seizures: Open-label Extension of a Randomized Clinical Study
    Klein, Pavel
    Krauss, Gregory
    Aboumatar, Sami
    Kamin, Marc
    NEUROLOGY, 2020, 94 (15)
  • [42] Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis -: An open, observational, extension study of a three-month, randomized, placebo-controlled trial
    Braun, J
    Brandt, J
    Listing, J
    Zink, A
    Alten, R
    Burmester, G
    Golder, W
    Gromnica-Ihle, E
    Kellner, H
    Schneider, M
    Sörensen, H
    Zeidler, H
    Reddig, J
    Sieper, J
    ARTHRITIS AND RHEUMATISM, 2003, 48 (08): : 2224 - 2233
  • [43] A PLACEBO-CONTROLLED STUDY OF EFFICACY AND SAFETY OF ARIPIPRAZOLE ONCE-MONTHLY FOR LONG-TERM MAINTENANCE TREATMENT IN SCHIZOPHRENIA
    Eramo, A.
    Fleischhacker, W. W.
    Sanchez, R.
    Perry, P.
    Jin, N.
    Johnson, B.
    McQuade, R. D.
    Carson, W. H.
    Kane, J.
    EUROPEAN PSYCHIATRY, 2013, 28
  • [44] Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial
    Bleecker, Eugene R.
    FitzGerald, J. Mark
    Chanez, Pascal
    Papi, Alberto
    Weinstein, Steven F.
    Barker, Peter
    Sproule, Stephanie
    Gilmartin, Geoffrey
    Aurivillius, Magnus
    Werkstrom, Viktoria
    Goldman, Mitchell
    LANCET, 2016, 388 (10056): : 2115 - 2127
  • [45] Long-term efficacy and safety of omalizumab in patients with persistent uncontrolled allergic asthma: a systematic review and meta-analysis (vol 5, 8191, 2015)
    Lai, Tianwen
    Wang, Shaobin
    Xu, Zhiwei
    Zhang, Chao
    Zhao, Yun
    Hu, Yue
    Cao, Chao
    Ying, Songmin
    Chen, Zhihua
    Li, Wen
    Wu, Bin
    Shen, Huahao
    SCIENTIFIC REPORTS, 2015, 5
  • [46] A randomised double-blind, placebo-controlled, long-term extension study of the efficacy, safety and tolerability of fixed-dose combinations of aclidinium/formoterol or monotherapy in the treatment of chronic obstructive pulmonary disease
    D'Urzo, Anthony
    Rennard, Stephen
    Kerwin, Edward
    Donohue, James F.
    Lei, Alejhandra
    Molins, Eduard
    Leselbaum, Anne
    RESPIRATORY MEDICINE, 2017, 125 : 39 - 48
  • [48] Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, doubleblind, placebo-controlled,withdrawal, efficacy, and safety trial (vol 402, pg 555, 2023)
    Ramanan, A., V
    Quartier, P.
    Okamoto, N.
    LANCET, 2023, 402 (10401): : 528 - 528
  • [49] EPHEX: A PHASE 3 DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMISED STUDY TO EVALUATE LONG-TERM EFFICACY AND SAFETY OF OXALOBACTER FORMIGENES IN PATIENTS WITH PRIMARY HYPEROXALURIA
    Ariceta, Gema
    Schalk, Gesa
    Collard, Laure
    Abroug, Saoussen
    Moochhala, Shabbir
    Gould, Edward
    Boussetta, Abir
    Ben Hmida, Mohamed
    Jarraya, Faical
    Dee, Sudarsana
    Hunley, Tracy E.
    Banos, Ana
    Lindner, Elisabeth
    Dehmel, Bastian
    PEDIATRIC NEPHROLOGY, 2021, 36 (10) : 3304 - 3304
  • [50] A Phase II Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of Lenalidomide in Lumbar Radicular Pain with a Long-Term Open-Label Extension Phase A Phase II Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of Lenalidomide in Lumbar Radicular Pain with a Long-Term Open-Label Extension Phase
    Manning, Donald C.
    Gimbel, Joseph
    Wertz, Robert
    Rauck, Richard
    Cooper, Alyse
    Zeldis, Jerome B.
    Levinsky, Dale M.
    PAIN MEDICINE, 2017, 18 (03) : 477 - 487